Trials that use: Risk difference
New to this method? Read the tutorial →
4,772 results
- Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02067039).
- Evaluation of Reactogenicity and Safety of GSK Biologicals’ Rotarix™ (Human Rotavirus Vaccine) in Infants: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants: primary endpoint results, effect estimate with confidence interval,…
- Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Self-adhesive Hybrid Resin Composite Compared to a Traditional Composite Resin in Restorations of NCCLs: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Self-adhesive Hybrid Resin Composite Compared to a Traditional Composite Resin in Restorations of NCCLs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05019742).
- Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands: primary endpoint results, effect estimate with confidence interval,…
- Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure:…
- Evaluation of the Cosmetic Performance of AIR OPTIX® COLORS: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Cosmetic Performance of AIR OPTIX® COLORS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01398787).
- Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and…
- Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum: primary endpoint results, effect estimate with confidence…
- Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals’ HPV Vaccine in Healthy Indian Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02483416).
- Evaluation of the Implementation and Effectiveness of IPP-HPV: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Implementation and Effectiveness of IPP-HPV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02994290).
- Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Rectal Reflex Using Anal Acoustic Reflectometry: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Rectal Reflex Using Anal Acoustic Reflectometry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02782377).
- Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of the Safety and Performance of the HARMONI® Toric Lens: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Performance of the HARMONI® Toric Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation: primary endpoint results, effect estimate with confidence interval,…
- Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Trima Version 7.0 Platelets in PAS: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Trima Version 7.0 Platelets in PAS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02754440).
- Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of Wear Experience With a Daily Disposable Contact Lens: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Wear Experience With a Daily Disposable Contact Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04296877).
- EVARIndependent statistical analysis of Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210180).
- EVarQuitIndependent statistical analysis of EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262662).
- EVAS2Independent statistical analysis of EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Everolimus for Cancer With TSC1 or TSC2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Cancer With TSC1 or TSC2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201212).
- Everolimus for Children With Recurrent or Progressive Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Children With Recurrent or Progressive Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155920).
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVERZOTAIndependent statistical analysis of Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…